PAPER Xu H, Qiu Q, Hu P, Hoxha K, Jang E, O'Reilly M, Kim C, He Z, Marotta N, Changolkar L, Zhang B, Wu H, Schellenberg GD, Kraemer B, Luk KC, Lee EB, Trojanowski JQ, Brunden KR, Lee VM

MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons.

Acta Neuropathol. 2024 Mar 12;147(1):55. PubMed.

PAPER Yiğit T, Ata N, Dinçer M, Ülgü MM, Birinci Ş, Ayvalı MO

Insights from Turkey's big data: unraveling the preventability, pathogenesis, and risk management of Alzheimer's disease (AD).

Sci Rep. 2024 Mar 12;14(1):6005. PubMed.

PAPER Walton RL, Koga S, Beasley AI, White LJ, Griesacker T, Murray ME, Kasanuki K, Hou X, Fiesel FC, Springer W, Uitti RJ, Fields JA, Botha H, Ramanan VK, Kantarci K, Lowe VJ, Jack CR, Ertekin-Taner N, Savica R, Graff-Radford J, Petersen RC, Parisi JE, Reichard RR, Graff-Radford NR, Ferman TJ, Boeve BF, Wszolek ZK, Dickson DW, Ross OA, Heckman MG

Role of GBA variants in Lewy body disease neuropathology.

Acta Neuropathol. 2024 Mar 12;147(1):54. PubMed.

PAPER Amartumur S, Nguyen H, Huynh T, Kim TS, Woo RS, Oh E, Kim KK, Lee LP, Heo C

Neuropathogenesis-on-chips for neurodegenerative diseases.

Nat Commun. 2024 Mar 12;15(1):2219. PubMed.

PAPER Tsartsalis S, Sleven H, Fancy N, Wessely F, Smith AM, Willumsen N, Cheung TK, Rokicki MJ, Chau V, Ifie E, Khozoie C, Ansorge O, Yang X, Jenkyns MH, Davey K, McGarry A, Muirhead RC, Debette S, Jackson JS, Montagne A, Owen DR, Miners JS, Love S, Webber C, Cader MZ, Matthews PM

A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer's disease.

Nat Commun. 2024 Mar 12;15(1):2243. PubMed.

PAPER Peddinti V, Avaghade MM, Suthar SU, Rout B, Gomte SS, Agnihotri TG, Jain A

Gut instincts: Unveiling the connection between gut microbiota and Alzheimer's disease.

Clin Nutr ESPEN. 2024 Apr;60:266-280. Epub 2024 Feb 19 PubMed.

PAPER Duzel E, Schöttler M, Sommer H, Griebe M

Protocol: Prospective evaluation of feasibility, added value and satisfaction of remote digital self-assessment for mild cognitive impairment in routine care with the neotivCare app.

BMJ Open. 2024 Mar 12;14(3):e081159. PubMed.

PAPER Ozsurekci C, Satis NK, Demircan SK, Naharci MI

Association of Anticholinergic Drug Burden With Cognitive and Functional Decline Over Time in Dementia With Lewy Bodies: 1-Year Follow-Up Study.

Clin Neuropharmacol. 2024 Mar-Apr 01;47(2):48-53. PubMed.

PAPER Alosco ML, Tartaglia MC

Repetitive Blast Injury and CSF Alzheimer Disease Biomarkers: Navigating a Complex Narrative.

Neurology. 2024 Apr 9;102(7):e209294. Epub 2024 Mar 13 PubMed.

PAPER Li G, Iliff J, Shofer J, Mayer CL, Meabon J, Cook D, Pagulayan KF, Raskind MA, Zetterberg H, Blennow K, Peskind ER

CSF β-Amyloid and Tau Biomarker Changes in Veterans With Mild Traumatic Brain Injury.

Neurology. 2024 Apr 9;102(7):e209197. Epub 2024 Mar 13 PubMed.

PAPER Scekic-Zahirovic J, Benetton C, Brunet A, Ye X, Logunov E, Douchamps V, Megat S, Andry V, Kan VW, Stuart-Lopez G, Gilet J, Guillot SJ, Dirrig-Grosch S, Gorin C, Trombini M, Dieterle S, Sinniger J, Fischer M, René F, Gunes Z, Kessler P, Dupuis L, Pradat PF, Goumon Y, Goutagny R, Marchand-Pauvert V, Liebscher S, Rouaux C

Cortical hyperexcitability in mouse models and patients with amyotrophic lateral sclerosis is linked to noradrenaline deficiency.

Sci Transl Med. 2024 Mar 13;16(738):eadg3665. PubMed.

PAPER Marques C, Held A, Dorfman K, Sung J, Song C, Kavuturu AS, Aguilar C, Russo T, Oakley DH, Albers MW, Hyman BT, Petrucelli L, Lagier-Tourenne C, Wainger BJ

Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia.

Acta Neuropathol. 2024 Mar 13;147(1):56. PubMed.

PAPER Rai P, Sundarakumar JS, Basavaraju N, Kommaddi RP, Issac TG

Association between ApoE ε4 genotype and attentional function in non-demented, middle-aged, and older adults from rural India.

J Neurosci Rural Pract. 2024;15(1):117-125. Epub 2024 Jan 9 PubMed.

PAPER Wasielewska JM, Szostak K, McInnes LE, Quek H, Chaves JC, Liddell JR, Koistinaho J, Oikari LE, Donnelly PS, White AR

Patient-Derived Blood-Brain Barrier Model for Screening Copper Bis(thiosemicarbazone) Complexes as Potential Therapeutics in Alzheimer's Disease.

ACS Chem Neurosci. 2024 Apr 3;15(7):1432-1455. Epub 2024 Mar 13 PubMed.

PAPER Katariya RA, Sammeta SS, Kale MB, Kotagale NR, Umekar MJ, Taksande BG

Agmatine as a novel intervention for Alzheimer's disease: Pathological insights and cognitive benefits.

Ageing Res Rev. 2024 Apr;96:102269. Epub 2024 Mar 11 PubMed.